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Introduction to Substance Abuse and HIV Infec-
tion Among Young Adults
The time span determining young adulthood is imprecise and is a 
function of  psychosocial development and physical development 
which varies region to region and culture to culture. Studies 
have identified the age range to be between 16-40 years of  
age for young adulthood [1-3]. For the purpose of  addressing 
substance use and substance use disorders in the context of  
Human Immunodeficiency Virus (HIV) infection during young 
adulthood, the age range of  16-30 years has been selected to 
reflect a time when life goals are formulated, along with meeting 
the challenges of  independently facing a diverse, global and 
rapidly changing environment. This time frame, based on social 
norms, is the period of  sexual debut (average age of  first sex in 44 
countries is 18.4 years) [4] and the consequences of  first exposure 
to legal drugs, such as alcohol [5]. Globally, the median age for 
the initiation of  alcohol use has been reported at 16-19 years of  
age, with nearly half  of  those initiating between the ages of  14-21 
[5]. Exposure to alcohol in childhood or early adolescence and 
binge drinking in late adolescence confer an increased venerability 
to alcohol dependence as young adults [6, 7]. National surveys, 
globally, show that approximately 70% of  young adults consume 
alcohol and research studies show that young adults drink the 
most in their late teens to mid-twenties [8-11]. These data also 
show a gender component with more men being consumers of  
alcohol compared to women. Global burden of  disease studies 
have shown that alcohol use disorders have been reported as 
the highest risk factor for disability adjusted life-years for young 
adults 20-24 years of  age [12].
With regard to illicit drug use and young adults, prescription drug 
abuse is reported high in national surveys of  developed countries 
with approximately 6% of  young adults reporting non-medical 
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Abstract
Young adults comprise roughly one-quarter of  the global population and are at the developmental stage where personal 
life goals are formulated and personal independence is obtained. It is also the time of  sexual debut and exposure to illicit 
drug and alcohol use. Thus, young adulthood is a time of  high-risk for HIV transmission due to drug and alcohol use in the 
context of  sexual activity. Social-networking, gender norms, economic, educational, familial, personal identity and develop-
ment factors, among others, play a role in illicit drug and alcohol use and HIV infection in young adults. It is estimated that 
young adults account for 42% of  new HIV infections globally, and that 4 million young adults living with HIV reside in 
sub-Saharan Africa. In Central Asia, Eastern Europe and the United States key populations are important subpopulations 
of  young adults at high-risk for living with HIV. Subpopulations of  young adults, particularly key populations, consume 
illicit drugs and alcohol with high-risk sexual and injection activity, thereby establishing connections between substance 
use/injection drug use/substance use disorders and HIV infection. Globally, interventions that comprise evidence-based 
prevention, care and treatment of  substance use disorders targeting young adults and prioritizing treatment of  substance 
use disorders as part of  HIV care and treatment are vital to reduce the transmission of  HIV infection and promote good 
clinical outcomes for young adults at-risk for and living with HIV.
Keywords: Young adults; Drug Use; Substance Use Disorder Treatment; HIV Infection; Alcohol Use.
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use of  prescription drugs in the last month [13]. One in six urban 
young adults attending partying venues has been reported to 
combine illicit drug use with prescription drug abuse [14]. Of  those 
abusing prescription drugs, 66% used the prescription drug with 
at least one illicit drug in common combination with marijuana, 
cocaine, ecstasy and psychotropic drugs. The misuse of  over-the 
counter medications can also result in serious adverse medical 
events particularly when mixed with alcohol and other drugs [15]. 
Globally, young adults who misuse over-the-counter medications 
report a higher prevalence of  hazardous alcohol use and illicit 
drug use [15-17]. Female sex workers and male clients in resource 
limited settings, who report over-the-counter or prescription drug 
abuse, are at higher risk for HIV infection through unsafe sex 
practices [18, 19]. Illicit drugs most identified with an elevated risk 
of  HIV transmission, either through injection drug practices or 
high-risk sexual behavior, are opioids, amphetamines and cocaine 
[20]. Globally, it has been reported that the median age of  cocaine 
use is 21-24 years of  age with nearly half  initiating cocaine use 
between 19-28 years of  age [5]. An estimate of  global use of  
these illicit drugs can be found in the World Drug Report where 
it is reported that between 3.5 and 7.0% of  the global population 
(ages 15-64) has used an illicit drug in the previous year [21]. It is 
also estimated that 10% of  these individuals exhibit symptoms of  
a substance use disorder, indicating an uncontrolled use and abuse 
of  the illicit drug. These latter individuals are at highest risk for 
either injection or sexual behaviors that place the illicit drug user 
at elevated risk for HIV transmission. Thus for young adults, data 
from global studies and national surveys show a convergence of  
the consequences of  the initiation of  drug and alcohol use along 
with a time of  sexual debut, linking the young adult period with 
an elevated risk of  HIV infection.
Etiology of  HIV Prevalence and Substance Abuse 
Prior to Young Adulthood
While young adulthood is a time of  high-risk for the transmission 
of  HIV due to drug and alcohol use in the context of  sexual 
activity, the prevalence of  HIV infection in young adults 
comprises both infection prior to and during young adulthood. 
Prior to young adulthood, HIV infection can result from mother 
to child transmission (MTCT) or infection during adolescents 
due to high-risk activities. For MTCT, numerous studies [22-25]
have documented that maternal use of  cocaine and other illicit 
drugs results in a greater than three-fold higher risk for vertical 
transmission of  HIV. This increased risk of  transmission is 
evident for drug-using pregnant women who do not receive anti-
retroviral therapy during pregnancy to reduce the risk of  perinatal 
vertical transmission [26]. Infants born with HIV infection have 
an excellent survival rate when provided anti-retroviral treatment 
under WHO treatment guidelines [27]. However, infants born 
with HIV infection have more factors associated with failure to 
thrive, and as they progress through childhood, adolescence and 
young adulthood experience poorer health and lower quality of  
life [28, 29]. These individuals, living with HIV, as they progress 
to young adulthood, have a higher risk of  prescription drug abuse, 
as well as, illicit drug and alcohol use due to both increase chronic 
health issues, as well as, the stigma and discrimination of  growing 
up with HIV infection [30]. In addition, research has shown a 
genetic component to addiction where allelic phenotypes of  
genes related to both the brain and nervous system contribute 
to the onset of  problematic drug and alcohol use, particularly in 
young adulthood [31]. Thus, the perfect storm forms for those 
acquiring HIV perinatally, comprising neonatal exposure to drugs 
and alcohol combined with genetic risk, chronic health conditions 
early in life, and poor quality of  life into young adulthood, a time 
of  onset for abuse of  drugs and alcohol. 
Another important risk factor for illicit drug and alcohol use, 
for individuals living with HIV as well as those without HIV, 
is growing up in a drug-using household [32]. Household and 
family substance use coupled with the stigma and discrimination 
of  HIV infection provides a high-risk environment for the 
early initiation of  illicit drug and alcohol use, along with sexual 
debut in adolescence or young adulthood. Growing up without 
the knowledge of  HIV infection is also an issue. Young adults 
with perinatal HIV infection, who receive a late diagnosis of  
HIV infection in their teens or early twenties, face a life changing 
event during a time of  developmental and emotional immaturity. 
Without significant support, these individuals are at-high risk for 
not only illicit drug and alcohol abuse and addiction, but also 
suicide and mental health disorders, such as major depression. 
Unfortunately, it is not uncommon in both resource rich and 
resource limited countries for young adults with perinatal HIV 
infection, and who receive limited health care services early in life, 
to be diagnosed with HIV infection in late adolescence or early 
young adulthood [33]. 
The early initiation of  drug and/or alcohol use during adolescence, 
the developmental stage prior to young adulthood, is a high-risk 
behavior for the acquisition of  HIV infection. The early initiation 
of  drug and/or alcohol use in adolescence results in increased 
sexual risk-taking with the potential exposure to HIV infection 
[34]. So, what influences the early initiation of  drug and/or alcohol 
use? Positive protective factors include a good adolescent-school 
relationship, as well as, good family- adolescent relationship 
which includes: positive parenting, parental involvement, family 
cohesion, family communication, parental monitoring of  peers, 
and parent-adolescent communication [35]. Promotional factors 
for drug and alcohol use include those that foster the social 
acceptance of  drug and alcohol use, such as household drug and/
or alcohol use, peer use of  drugs and alcohol, the easy availability 
of  alcohol and drugs, adolescent disengagement from school, 
poor family relationship(s) and poverty [5]. 
With regard to household drug/alcohol use, adolescents perinatally 
exposed to illicit drug use have a two fold increased risk in the use 
of  drugs or alcohol by age 15, as well as, an increased risk of  early 
sexual debut [36, 37]. In a low income setting, minority adolescents 
who were early initiators of  sexual activity also reported substance 
use and illicit drug selling [38]. In this setting, youth who reported 
continuous involvement in drug use also reported intense sexual 
involvement, as compared to sexual experimentation. A highest-
risk group for substance use and HIV transmission are homeless 
street youth. In both high income settings and low-income 
settings, street youth report daily use of  alcohol and illicit drugs, 
as well as, high-risk sexual activities, including survival sex, that 
is, the engagement in sex work because of  extreme need [39, 40]. 
The circumstance of  social estrangement is a key factor in the 
lack of  access and receipt of  health services for substance use 
disorders and HIV infection [41]. Socially estranged adolescents 
are frequently involved with the criminal justice system and are 
a population that has been shown to have repeated sexually 
transmitted diseases [42]. Behaviors that place these youth at 
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high-risk for HIV infection include binge-drinking, risky sexual 
encounters while intoxicated, intravenous drug use, and frequent 
incarceration [43-46]. A history of  arrest and detention has been 
shown to be a marker for both adolescent HIV infection risk and 
substance abuse [47].
Since illegal behaviors have been shown to be a marker for 
substance abuse and HIV infection risk, behavior screening of  
adolescents and young adults is an important tool for health care 
providers. Adolescents and young adults, who are key at risk 
populations (people who inject drugs, men who have sex with 
men, sex workers and transgendered individuals), are confronted 
with laws and community practices that frequently criminalize 
their behaviors. This criminalization places them at high risk 
for HIV infection, sustained violence and discrimination for 
their behaviors, plus impeded access to drug and HIV-related 
prevention, care and treatment [48]. These individuals, along 
with homeless young adults, experience more unprotected sex, 
sexually transmitted infections, HIV infection, unintended 
pregnancies, violence, mental health disorders and substance use 
disorders than young adults in the general population [49]. The 
result is a marginalized population of  young adults with the triple 
diagnosis of  HIV infection, substance use disorder and mental 
health disorders who are estranged from needed medical care and 
treatment. 
HIV infection is an epidemic among adolescent girls and young 
women in many parts of  the world [50]. In Eastern and Southern 
Africa, young girls account for 80% of  all new HIV infections 
and HIV/AIDS is the leading cause of  death for girls aged 15-
19. The vulnerability to HIV results from gender inequality, lack 
of  economic opportunity, intergenerational and transactional sex, 
stigma and discrimination due to sexual violence, forced marriage, 
trafficking and sex work. In Southwest Asia, roughly one-in-three 
trafficked women were determined to be living with HIV when 
provided health services [51]. Those trafficked into sex work have 
also been shown to be high consumers of  drugs and alcohol [52]. 
Thus, for young women, the convergence of  young age, sexual 
activity and drug or alcohol use presents a high-risk for HIV-
infection and other social consequences [53]. 
Prevalence of  Substance Use/Substance Use 
Disorders and HIV Infection in Young Adults
Currently, there are roughly 1.6 billion young people 12-24 years 
of  age and, thus, young adults represent roughly one-quarter of  
the global population [54, 55]. With regard to HIV infection, 
young people aged 15-24 account for 42% of  new HIV infections 
and roughly 4 million of  these young adults living with HIV live in 
sub-Saharan Africa [54]. AIDS is the number one cause of  death 
for young adults in Africa. Young women in sub-Saharan Africa 
account for 58% of  the young adults living with HIV [55]. Africa 
has one of  the highest alcohol per capita consumption levels in 
young adults at 19.5 liters per person per year, as well as emerging 
regional drug abuse epidemics with heroin abuse along the coast 
in Eastern Africa, stimulant use in Southern and Western Africa 
[56, 57]. Local situations vary with a high variability of  multiples 
substances including local brews and spirts “gongo”, as well as, 
cannabis “bhang” or other locally grown plants. Youths start using 
substances between the ages of  10 and 15 years and graduate to 
more potent substances as young adults [58].
In Central Asia and Eastern Europe, the HIV epidemic is driven 
by injection drug use and focused in key populations [59]. Recent 
studies have shown that young adults who were homeless were 
most likely to be living with HIV and injecting illicit drugs [60, 
61]. Studies have shown that key populations who initiate drug 
use as young adults may have a 20-fold risk for HIV infection 
and are less likely to seek HIV services [62]. In Central Asia and 
Eastern Europe, there are an estimated 3.7 million people who 
inject drugs, nearly one-quarters of  the global total [63].
In the United States, young adults are the only age group to 
experience a rise in new HIV infection with nearly 40% of  new 
infections occurring between the ages of  13-29 [64]. Men who 
have sex with men account for 72% of  HIV infections in people 
under the age of  25. Also in the United States, there is a rapid 
onset of  substance use disorders for young adults under the age 
of  20, with one-in-three young adults reporting lifetime alcohol 
use and 24% reporting illicit drug use- mostly marijuana or 
prescription drug abuse [65]. 
Elsewhere, in Asian countries, numerous studies have shown that 
for key populations the risk for HIV infection is substantial, but 
becomes even greater with alcohol or injection drug use [66-69]. 
In South America, cocaine is the drug of  choice. Studies have 
shown young adult crack cocaine users experience health and 
economic marginalization, an elevated risk for HIV infection and 
compromised health along with poor health services utilization 
[70-72]. In the Dominican Republic, a recent study has addressed 
alcohol use in young adults in the context of  risk for HIV 
infection [73]. This study notes that 18% of  AIDS cases occur 
in young adults between the ages of  15-24, with 29% of  young 
adults reporting sexual debut before the age of  15. These sexually 
active young adults are drug and alcohol experienced with one-in-
three reporting binge drinking prior to the age of  12. Hazardous 
chronic alcohol use is common with 25% of  girls and 35% of  
boys reporting heavy episodic drinking.
 
Thus from Europe, Asia, Africa and the Americas-globally-the 
prevalence of  substance use/substance use disorders and HIV 
infection in young adults is elevated and can be characterized as 
a heavy health burden. The relationship between substance use 
disorders and HIV infection is bidirectional and multifaceted 
with multiple components. The bidirectional nature of  the 
relationship is the sequential exposure to either the HIV virus or 
illicit drugs or alcohol. The common direction is initial exposure 
to illicit drugs and alcohol followed by exposure to the HIV virus 
through high-risk sexual encounters or high-risk injection drug 
practices. Alternatively, young adults who acquire HIV infection 
through vertical transmission can initiate illicit drug or alcohol 
use early in life in adolescence or as young adults. In addition, 
in a less common scenario, young adults could be exposed to 
both the HIV virus and illicit drugs or alcohol in utero during 
pregnancy by women living with HIV who are using/addicted to 
drugs or alcohol during the pregnancy. The components of  the 
relationship between substance use/substance use disorders and 
HIV infection in young adults comprise social, economic, familial, 
educational, legal, and human rights issues. These issues describe 
the young adult subpopulations (see Table 1) and risk factors as 
noted above in the etiology of  exposure to the HIV virus and illicit 
drugs and alcohol. Regardless of  the timing of  the exposure to 
illicit drugs and alcohol, young adults who have hazardous levels 
of  consumption or who are dependent on illicit drugs or alcohol, 
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need to seek medical care through comprehensive substance 
abuse treatment programs. The importance and prioritization of  
seeking and receiving substance use disorder treatment cannot be 
over stated. Recent studies have shown that people who inject 
drugs that are in care or treatment are more likely to receive HIV 
testing and people living with HIV are more likely to have reduced 
survival due to drug or alcohol use [74, 75].
Prioritizing Comprehensive Substance Abuse 
Treatment Programs Targeting Young Adults to 
Impact Global Health
Young adults should routinely seek medical care from health care 
providers who are familiar with and have experience in providing 
primary care to individuals through their developmental stage(s) 
in life. In seeking care and treatment for substance use/substance 
use disorders in young adulthood, health care providers who are 
familiar with the stages of  substance use progression and patterns 
of  adolescent drug and alcohol use can provide evidence-based 
interventions, such as screening and brief  interventions, to 
reduce hazardous levels of  consumption [76]. Based on the level 
of  abuse, an individual treatment plan should be developed as 
part of  the assessment and intake process [77]. If  the young 
adult is not ready for treatment, then the healthcare provider, 
even in a resource limiting setting, can engage the young adult 
with motivational interviewing techniques with the goal of  
reducing consumption levels of  alcohol and other drugs [78, 79]. 
For young adults seeking or entering treatment, comprehensive 
treatment programs that provide services beyond treatment of  
the substance use disorder are effective evidence-based programs 
[80-82]. These programs address the health needs of  the young 
adults and through case management and other interventions, as 
well as addressing family issues and support, educational, legal/
criminal justice and economic issues, including the stigma and 
discrimination associated with addiction. These programs also 
provide peer recovery support for the young adults as part of  
the reintegration effort with social change [83]. For people living 
with HIV in low and middle income countries, the integration of  
treatment for substance use disorders with HIV primary care is 
critical since screening, diagnosis and management of  substance 
use disorders has high impact in achieving good HIV clinical 
outcomes [84, 85]. 
The effective treatment for substance use disorders for young 
adults living with HIV is important since access and adherence 
to anti-retroviral medication regimens leads to a normal and 
productive life span, as well as, dramatically decreasing the risk of  
HIV transmission. Substance use disorders interrupt normal life 
progression through biological changes in the immune system, 
increased poor nutrition and health, changes in socio-economic 
status, increased drug-related mortality, reduced access and 
uptake of  medical care, as well as, poor adherence to medication 
regimens [86-89]. Treatment of  substance use disorders in 
young adults, in addition to relapse prevention interventions and 
recovery support services reduces the number of  young adults 
lost to follow-up in HIV care and treatment, as well as, a reduction 
in HIV transmission [84, 85, 90-92]. 
The Challenges in Treatment of  Substance Use 
Disorders and HIV Infection in Young Adults
Numerous studies have identified the substantial challenges, 
particularly in low and middle income countries, in accessing 
and retaining adults living with HIV in HIV care and treatment 
[93-95]. These studies have identified patient, clinical and 
societal challenges that include: remote clinic locations, lack of  
transportation, fear of  disclosing status, stigma, long clinic wait 
times, clinic staff  shortages, fear of  drug side effects, need to 
take time off  from work and poverty. These challenges result in 
a cycling of  adults in and out of  care, particularly for men and 
young adults. Interventions to promote retention through the 
clinical care cascade comprise: 1) health system interventions, 
such as integration of  services; decentralization, task-shifting, 
use of  technology; 2) patient convenience and accessibility, 
such as point of  care services, home based care and treatment, 
case management, use of  first line medications; 3) behavioral 
interventions and peer support, such as patient referral and 
education, patient navigators, improved communication; and 4) 
incentives, such as food support or cash incentives [93, 95]. 
Focusing on young adults with substance use disorders, three 
additional challenges can be identified: (a) transitioning from 
adolescent care to adult care for those individuals who are living 
with HIV prior to reaching young adulthood and who were in care, 
(b) accessing HIV care and treatment from HIV testing with the 
dual comorbidities of  substance use disorder and HIV infection 
and (c) out-of-care young adults disengaged from medical care. 
For all of  these challenges, providing a young adult friendly venue 
Table 1. Subpopulations of  Young Adults and the Etiology of  Substance Abuse and HIV Infection.
Young Adult Subpopulation Etiology
Living with HIV through vertical transmission
Material use of  cocaine and other illicit drugs Risk for prescription drug 
abuse/ street drugs/alcohol use as young adult 
Recent diagnosis of  HIV infection in adolescence Risk of  drug or alcohol use and suicide
Living in a drug or alcohol using household Early initiation of  drug/alcohol use or dependence
High-risk sexual encounters Initiation of  drug/alcohol use as adolescent
Homeless street youth/ young adult Daily alcohol/drug use and survival sex
Criminal justice involved youth/young adults Marker for drug abuse and HIV infection
Key Populations High risk for HIV infection and drug/alcohol use or dependence
Young women- trafficked sex workers Drug/alcohol use as part of  sex work, as well as unsafe sex practices
Young women-sexual violence, forced marriage Drug/alcohol use as self-medication of  trauma 
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that integrates comprehensive services for treatment of  substance 
use disorder and HIV care and treatment provides the optimal 
opportunity for engagement and retention in care with good 
clinical outcomes [96].
For transitioning youth into adult HIV care, optimal care includes 
a formal plan for the transition from pediatrics/adolescent/ 
family care to adult care, as well as, a formal written policy on 
transfer [97, 98]. The plan should be individualized for each youth 
based on specific developmental milestones addressing cognitive 
development, mental health, medication adherence, sexuality, 
reproductive and gender issues, stigma and discrimination, peer 
support, socioeconomic status and payment for services. A 
recent study [99] pilot tested a formal transfer protocol to assist 
the transition to adult care. Using the “Movin Out” transitioning 
protocol approximately half  the youth were able to transition to 
adult care. Reasons for not transitioning were relocation, attrition, 
lost to follow-up and transfer to another service. Interestingly, 
substance abusing youth were successful in transitioning to adult 
care using this protocol [99].
For young adults with substance use disorders and diagnosed 
with HIV infection, accessing HIV care and treatment can be 
challenging. These individuals can face health system challenges, 
as well as, social and individual challenges [100,101]. These 
challenges include stigma, long waits for services, patient provider 
relationships, system navigation for health services and social 
services, and lack of  family and peer support. Overcoming these 
barrier to HIV care are critical since patients in HIV treatment 
that also are retained in care report better treatment outcomes 
[101]. Interventions that promote linkage to HIV care and 
treatment include utilizing care coordinators to promote linkage 
and utilization of  care, providing information and education 
on HIV care, providing motivational counseling, utilizing care 
navigators, providing coordinated services with good patient-
provider communication along with social services [100-102].
For young adults with substance use disorders who are out of  
care, the priority is to initiate the Test and Treat algorithm [103]. 
Thus, in outreach efforts to these key populations, testing for HIV 
infection with concomitant rapid initiation of  care and treatment 
is paramount. Studies have shown community-based HIV testing 
with facilitated linkage to care and treatment results in improved 
access to care and initiation of  anti-retroviral treatment [104]. 
Home-based testing, mobile testing and self-testing were found to 
be accepted and facilitated access to care and entry into treatment 
for young adults [104, 105]. Subsequent to the initiation of  HIV 
care and treatment, young adults can be further stabilized with 
entry into comprehensive substance abuse treatment. Thus, 
interventions have been identified that successfully address the 
challenges encountered by young adults with substance use 
disorders in accessing and receiving HIV care and treatment.
Recommendations
Because of  the association between substance use disorders and 
HIV infection, the overarching recommendation is to leverage 
the large global effort to control the HIV epidemic and further 
address the growing epidemic of  substance use disorders in 
young adults. While there are substantial efforts in the global 
programs to address HIV related injection drug use, a greater 
effort is needed to address the early use of  drugs and alcohol 
in young adults and adolescents. Substance use disorders can be 
addressed through global, national, regional and local prevention, 
care and treatment programs. Substance use prevention, care and 
treatment programs impacting young adults need to be targeted 
to developmental stages, started at preadolescence, and continued 
through adolescent stages. Such programs need to reinforce 
protective factors that promote abstinence for illicit drug and 
alcohol use, as well as provide resiliency for those young adults 
exposed and dependent on illicit drugs and alcohol. Effective, 
evidence-based treatment programs are needed that target the 
developmental stages of  young adults including gender-based, key 
population focused and trauma-informed care and treatment, as 
part of  the comprehensive package of  services [106-108]. Salient 
specific recommendations are presented in Table 2.
Table 2. Salient recommendations addressing substance use and substance use disorder treatment in young adults living 
with HIV.
Prevention and Awareness
• Integrate drug and alcohol prevention components into global and national HIV awareness campaigns 
• Develop educational materials on the linkage between HIV infection and drugs and alcohol targeted to 
young adults young adult  
• Develop national drug and alcohol strategies and action plans and address informal and formal alcohol 
production, access and distribution  
• Develop and promote community recovery activities and events 
• Develop young adult social networking tools related to prevention of  drug and alcohol use 
• Integrate screening and brief  interventions for drug and alcohol use in prenatal HIV programs 
• Integrate HIV prevention efforts into drug and alcohol treatment programs
Care and Treatment
• Implement, evaluation and scale-up effective evidence based comprehensive substance abuse treatment for 
 young adults 
• Integrate substance use disorder treatment into HIV care and treatment programs 
• Promote gender-based treatment programs, key population focused programs and trauma-informed care 
 for violence-experienced individuals 
• Promote the formation of  recovery oriented systems of  care and peer-based recovery programs  
• Develop drug court programs for young adults to reduce incarceration of  young adults for drug /alcohol 
 dependence 
• Train public safety officers on drug /alcohol dependence as a health disorder; train on the use of  overdose 
 prevention medications
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Conclusion
The prevalence of  substance use and substance use disorders in 
young adults living with and at high risk for HIV is high with 
the need to prioritize access to and retention in treatment for 
substance use disorders as part of  HIV prevention, care and 
treatment in low and middle income countries. Leveraging the 
global effort to reduce HIV epidemic to provide programming 
for young adults living with and high risk for HIV and who use 
and abuse illicit drugs and alcohol will significantly impact the 
ability to reach the global goal of  controlling the HIV epidemic.
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